Giao dịch BB Biotech AG - BION CFD

Founded in 1993, BB Biotech is one of the world’s leading biotech investors. The Swiss company primarily invests in biotechnological firms that operate in various sectors, including oncology, cardiovascular, autoimmune, metabolic and infectious diseases. BB Biotech’s portfolio consists of 20-35 companies, such as Celgene, Incyte, Ionis Pharmaceuticals, Gilead, Vertex Pharmaceuticals, Radius Health, Neurocrine Biosciences, Alexion Pharmaceuticals, Agios Pharmaceuticals, Novo Nordisk, etc. Headquartered in Kusnacht, Switzerland, the BB Biotech share price (BION) is set and traded on the SIX Swiss Exchange, Frankfurt Stock Exchange and Borsa Italiana.